{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:54:08Z","timestamp":1771998848194,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40258-024-00891-3","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T16:01:42Z","timestamp":1718035302000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand"],"prefix":"10.1007","volume":"22","author":[{"given":"Rungroj","family":"Krittayaphong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-2789","authenticated-orcid":false,"given":"Unchalee","family":"Permsuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"2","key":"891_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217\u201321.","journal-title":"Int J Stroke"},{"issue":"12","key":"891_CR2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500\u201310.","journal-title":"Eur Heart J"},{"issue":"1","key":"891_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12872-018-0911-4","volume":"18","author":"R Krittayaphong","year":"2018","unstructured":"Krittayaphong R, Winijkul A, Methavigul K, Wongtheptien W, Wongvipaporn C, Wisaratapong T, et al. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study. BMC Cardiovasc Disord. 2018;18(1):174.","journal-title":"BMC Cardiovasc Disord"},{"issue":"12","key":"891_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/europace\/euab327","volume":"24","author":"HF Tse","year":"2022","unstructured":"Tse HF, Teo WS, Siu CW, Chao TF, Park HW, Shimizu W, et al. Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society atrial fibrillation registry. Europace. 2022;24(12):1889\u201398.","journal-title":"Europace"},{"issue":"5","key":"891_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"1","key":"891_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"891_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154(5):1121\u2013201.","journal-title":"Chest"},{"issue":"1","key":"891_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"TF Chao","year":"2022","unstructured":"Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022;122(1):20\u201347.","journal-title":"Thromb Haemost"},{"issue":"1","key":"891_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013156.","journal-title":"Circulation"},{"issue":"1","key":"891_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12872-020-01330-6","volume":"20","author":"T Liu","year":"2020","unstructured":"Liu T, Yang HL, Gu L, Hui J, Omorogieva O, Ren MX, et al. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study. BMC Cardiovasc Disord. 2020;20(1):22.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"891_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ihj.2020.11.152","volume":"73","author":"CG Bahuleyan","year":"2021","unstructured":"Bahuleyan CG, Namboodiri N, Jabir A, Lip GYH, Koshy AG, Shifas BM, et al. One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry. Indian Heart J. 2021;73(1):56\u201362.","journal-title":"Indian Heart J"},{"key":"891_CR12","doi-asserted-by":"crossref","unstructured":"Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assessment (Winchester, Engl). 2007;11(38):iii\u2013iv, ix\u201366.","DOI":"10.3310\/hta11380"},{"issue":"8","key":"891_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11886-015-0618-4","volume":"17","author":"SM Singh","year":"2015","unstructured":"Singh SM, Wijeysundera HC. Cost-effectiveness of novel oral anticoagulants for stroke prevention in non-valvular atrial fibrillation. Curr Cardiol Rep. 2015;17(8):61.","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"891_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","volume":"44","author":"AR Harrington","year":"2013","unstructured":"Harrington AR, Armstrong EP, Nolan PE Jr, Malone DC. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke. 2013;44(6):1676\u201381.","journal-title":"Stroke"},{"issue":"7","key":"891_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/heartjnl-2011-300646","volume":"98","author":"AR Kansal","year":"2012","unstructured":"Kansal AR, Sorensen SV, Gani R, Robinson P, Pan F, Plumb JM, et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart. 2012;98(7):573\u20138.","journal-title":"Heart"},{"issue":"10","key":"891_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.clinthera.2014.08.016","volume":"36","author":"S Jarungsuccess","year":"2014","unstructured":"Jarungsuccess S, Taerakun S. Cost-utility analysis of oral anticoagulants for nonvalvular atrial fibrillation patients at the police general hospital, Bangkok, Thailand. Clin Ther. 2014;36(10):1389-1394.e4.","journal-title":"Clin Ther"},{"issue":"3","key":"891_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.hlc.2019.02.187","volume":"29","author":"P Dilokthornsakul","year":"2020","unstructured":"Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U. Cost-effectiveness analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in Thai patients with non-valvular atrial fibrillation. Heart Lung Circ. 2020;29(3):390\u2013400.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"891_CR18","doi-asserted-by":"publisher","first-page":"1447828","DOI":"10.1080\/16549716.2018.1447828","volume":"11","author":"D Cameron","year":"2018","unstructured":"Cameron D, Ubels J, Norstrom F. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. Glob Health Action. 2018;11(1):1447828.","journal-title":"Glob Health Action"},{"issue":"1","key":"891_CR19","doi-asserted-by":"publisher","first-page":"1717030","DOI":"10.1080\/20016689.2020.1717030","volume":"8","author":"JA McDougall","year":"2020","unstructured":"McDougall JA, Furnback WE, Wang BCM, Mahlich J. Understanding the global measurement of willingness to pay in health. J Mark Access Health Policy. 2020;8(1):1717030.","journal-title":"J Mark Access Health Policy."},{"key":"891_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CEOR.S38062","volume":"5","author":"M Thavorncharoensap","year":"2013","unstructured":"Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Clinicoecon Outcomes Res CEOR. 2013;5:29\u201336.","journal-title":"Clinicoecon Outcomes Res CEOR"},{"issue":"1","key":"891_CR21","first-page":"50","volume":"36","author":"CT Liao","year":"2020","unstructured":"Liao CT, Lee MC, Chen ZC, Ku LE, Wang JD, Toh HS. Cost-effectiveness analysis of oral anticoagulants in stroke prevention among patients with atrial fibrillation in Taiwan. Acta Cardiol Sin. 2020;36(1):50\u201361.","journal-title":"Acta Cardiol Sin"},{"issue":"3","key":"891_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.26599\/1671-5411.2023.03.008","volume":"20","author":"R Krittayaphong","year":"2023","unstructured":"Krittayaphong R, Pumprueg S, Kaewkumdee P, Yindeengam A, Lip GY. Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry. J Geriatr Cardiol. 2023;20(3):163\u201373.","journal-title":"J Geriatr Cardiol"},{"issue":"8","key":"891_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1\u201328.","journal-title":"J Stat Softw"},{"key":"891_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modeling methods for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Claxton K, Sculpher M. Decision modeling methods for health economic evaluation. Oxford: Oxford University Press; 2006."},{"key":"891_CR25","unstructured":"Riewpaiboon A. Standard cost lists for health technology assessment: Health Intervention and Technology Assessment Program (HITAP); 2011."},{"key":"891_CR26","unstructured":"Bank of Thailand. Foreign exchange rates 2023 [cited 23 May 2023]. Available from https:\/\/www.bot.or.th\/thai\/_layouts\/application\/exchangerate\/exchangerate.aspx"},{"issue":"5","key":"891_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","volume":"18","author":"J Pattanaphesaj","year":"2018","unstructured":"Pattanaphesaj J, Thavorncharoensap M, Ramos-Go\u00f1i JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):551\u20138.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"Suppl 5","key":"891_CR28","first-page":"S50","volume":"97","author":"U Permsuwan","year":"2014","unstructured":"Permsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thailand. 2014;97(Suppl 5):S50\u20138.","journal-title":"J Med Assoc Thailand"},{"issue":"Suppl 5","key":"891_CR29","first-page":"S59","volume":"97","author":"S Limwattananon","year":"2014","unstructured":"Limwattananon S. Sensitivity analysis for handling uncertainty in an economic evaluation. J Med Assoc Thailand. 2014;97(Suppl 5):S59\u201364.","journal-title":"J Med Assoc Thailand"},{"issue":"1","key":"891_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1253\/circj.CJ-18-0655","volume":"83","author":"Y Koretsune","year":"2018","unstructured":"Koretsune Y, Etoh T, Katsuda Y, Suetsugu T, Kumeda K, Sakuma I, et al. Risk profile and 1-year outcome of newly diagnosed atrial fibrillation in Japan\u2014insights from GARFIELD-AF. Circ J. 2018;83(1):67\u201374.","journal-title":"Circ J"},{"issue":"38","key":"891_CR31","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","volume":"37","author":"JP Bassand","year":"2016","unstructured":"Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, et al. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J. 2016;37(38):2882\u20139.","journal-title":"Eur Heart J"},{"key":"891_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijcard.2014.11.182","volume":"180","author":"GY Lip","year":"2015","unstructured":"Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. Int J Cardiol. 2015;180:246\u201354.","journal-title":"Int J Cardiol"},{"issue":"9921","key":"891_CR33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet (Lond, Engl). 2014;383(9921):955\u201362.","journal-title":"Lancet (Lond, Engl)."},{"issue":"4","key":"891_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/jcpt.13575","volume":"47","author":"H Zhou","year":"2022","unstructured":"Zhou H, Nie X, Jiang M, Dong W. Cost-effectiveness of anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation in mainland China. J Clin Pharm Ther. 2022;47(4):523\u201330.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"891_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s40273-018-0741-3","volume":"37","author":"T Rattanachotphanit","year":"2019","unstructured":"Rattanachotphanit T, Limwattananon C, Waleekhachonloet O, Limwattananon P, Sawanyawisuth K. Cost-effectiveness analysis of direct-acting oral anticoagulants for stroke prevention in thai patients with non-valvular atrial fibrillation and a high risk of bleeding. Pharmacoeconomics. 2019;37(2):279\u201389.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"891_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCOUTCOMES.108.793406","volume":"2","author":"GA Diamond","year":"2009","unstructured":"Diamond GA, Kaul S. Cost, effectiveness, and cost-effectiveness. Circ Cardiovasc Qual Outcomes. 2009;2(1):49\u201354.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"891_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.722927","volume":"9","author":"HC Turner","year":"2021","unstructured":"Turner HC, Archer RA, Downey LE, Isaranuwatchai W, Chalkidou K, Jit M, et al. An introduction to the main types of economic evaluations used for informing priority setting and resource allocation in healthcare: key features, uses, and limitations. Front Public Health. 2021;9: 722927.","journal-title":"Front Public Health"},{"issue":"1","key":"891_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5334\/gh.774","volume":"15","author":"M Di Cesare","year":"2020","unstructured":"Di Cesare M, Jarvis JD, Scarlatescu O, Leng X, Zaidel EJ, Burrone E, et al. NOACs added to WHO\u2019s essential medicines list: recommendations for future policy actions. Glob Heart. 2020;15(1):67.","journal-title":"Glob Heart"},{"issue":"9","key":"891_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2471\/BLT.20.278473","volume":"99","author":"I Neumann","year":"2021","unstructured":"Neumann I, Schunemann HJ, Bero L, Cooke G, Magrini N, Moja L. Global access to affordable direct oral anticoagulants. Bull World Health Organ. 2021;99(9):653\u201360.","journal-title":"Bull World Health Organ"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-024-00891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-024-00891-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-024-00891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:24:04Z","timestamp":1724408644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-024-00891-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s40258-024-00891-3","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"14 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study used the data from the COOL-AF Thailand, which was approved by the Central Research Ethics Committee (Certificate Number COA-CREC003\/2014).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication (from Patients\/Participants)"}},{"value":"Data used in this study come from the COOL-AF Thailand together with the published literature as shown in Table  and the reference list for further information. Data used in the model were available upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"The model was shared for the peer review process. The authors can provide more details upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"RK initiated the study concept and data collection. UP initiated the study methodology, performed the data analysis. UP and RK interpreted the results, drafted the manuscript, and critically revised the manuscript. All authors approved the final version to be submitted.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}